Top

Published in:

01-07-2006 | Original Article

Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study

Authors: M. Iki, A. Morita, Y. Ikeda, Y. Sato, T. Akiba, T. Matsumoto, H. Nishino, S. Kagamimori, Y. Kagawa, H. Yoneshima ·, For the JPOS Study Group

Published in: Osteoporosis International | Issue 7/2006

Abstract

Introduction

The predictive value of biochemical markers of bone turnover for subsequent change in bone density in a population sample of healthy women with a wide range of ages has not been fully established.

Methods

We followed 1,283 women aged 15–79 years at baseline selected randomly from the inhabitants of three areas in Japan for 6 years, and examined 1,130 subjects with no disease or administration of drugs affecting bone metabolism. The annual change in bone density at the spine, total hip, and distal one third of the radius was determined during the follow-up period by dual x-ray absorptiometry and was compared among the groups using different levels of biochemical markers at baseline, including serum osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP), free and total (tDPD) forms of immunoreactive deoxypyridinoline, and type I collagen crosslinked C-terminal telopeptide (CTX) in urine.

Results

Premenopausal women aged 45 years or older with elevated levels of OC, bone ALP, CTX, or tDPD showed significantly greater bone loss at most skeletal sites during the follow-up period than those with lower levels, after adjustment for the effects of age, height, weight, dietary calcium intake, regular exercise, and current smoking. The greatest coefficient of determination of the model was observed in the association between CTX and bone loss at the hip during the first 3 years of follow-up (42.8%). These subjects were pooled with perimenopausal women at baseline, and those who still menstruated at follow-up in this pooled group showed significant but more modest associations, whereas those who entered menopause during the follow-up period showed clear associations. However, early postmenopausal women with less than 5 or 10 years since menopause showed an association that was limited mostly to the distal radius, and other postmenopausal groups had virtually no association.

Conclusion

Biochemical markers of bone turnover may predict bone loss in women undergoing menopausal transition but may not predict bone loss in postmenopausal women.

Christiansen C, Riis BJ, Rodbro P (1987) Prediction of rapid bone loss in postmenopausal women. Lancet 1:1105–1108PubMedCrossRef

Christiansen C, Riis BJ, Rodbro P (1990) Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporos Int 1:35–40PubMedCrossRef

Slemenda C, Hui SL, Longcopy C, Johnston CC (1987) Sex steroids and bone mass: a study of change about the time of menopause. J Clin Invest 80:1261–1269PubMedCrossRef

Johansen JS, Riis BJ, Delmas PD, Christiansen C (1988) Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 18:191–195PubMed

Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367–373PubMedCrossRef

Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC (1996) Sex steroids, bone mass and bone loss: a prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 97:14–21PubMed

Garnero P, Sornay-rendu E, Duboeuf F, Delmas PD (1999) Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614–1621PubMedCrossRef

Cosman F, Nieves J, Wilkinson C, Schnering D, Shen V, Lindsay R (1996) Bone density change and biochemical indices of skeletal turnover. Cacif Tis Int 58:236–243

Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y Tsuchida C, Yamamoto K, Ishii Y (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25:59–67PubMedCrossRef

10.

Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J (1999) The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. J Bone Miner Res 14:1583–1595PubMedCrossRef

11.

Roggers A, Hannon RA, Eastell R (2000) Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Re 15:1398–1404CrossRef

12.

Chaki, O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I (2000) The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 15:1537–1544PubMedCrossRef

13.

Chapurlat RD, Garnero P, Sorney-Rendu E, Arlot ME, Claustrat B, Delmas PD (2000) Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 11:493–498PubMedCrossRef

14.

Dennison E, Eastel R, Fall CHD, Kellingray S, Wood PJ, Cooper C (1999) Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporos Int 10:384–391PubMedCrossRef

15.

Melton LJ 3rd, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (2000) Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 15:24–31PubMedCrossRef

16.

Delmas PD, Estell R, Garnero P, Seibel MJ, Stapan J (2000) A position paper on the use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11(Suppl 6):S2–S17PubMedCrossRef

17.

Stepan JJ (2000) Prediction of bone loss in postmenopausal women. Osteoporos Int 11(Suppl 6):S45–S54PubMedCrossRef

18.

Iki M, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F (2001) Bone mineral density of the spine, hip and distal forearm in representative samples of the Japanese female population: Japanese Population-Based Osteoporosis (JPOS) Study. Osteoporos Int 12:529–537PubMedCrossRef

19.

Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-Based Osteoporosis (JPOS) Study. Osteoporos Int 15:981–991PubMedCrossRef

20.

Kawaguchi H, Matsumoto T, Kurokawa T, Orimo H, Mizunashi K, Takuwa Y, Niimi H, Shiraki M, Ohara T, Shishiba Y, Tsuchiya Y, Takahshi H, Takatsuki K, Seino Y, Morii H, Fujita T, Okamoto S, Ogata E (1990) Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies. Clin Endocrinol 38:1291–1296 (in Japanese)

21.

Garnero P, Delmas PD (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046–1053PubMedCrossRef

22.

Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C (1994) Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022–2025PubMed

23.

Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ (1994) Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643–1649PubMed

24.

Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT jr, Segre GV (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364–1367PubMed

25.

Suzumura E, Watanabe Y, Suzuki T, Yonezawa M, Yamauchi S, Ishigami T, Takezawa J, Ichikawa M, Seino Y (1992) Study of 1,25(OH)2D RPA kit using bovine mammary gland receptor and non-HPLC purification. Clin Endocrinol 40:1211–1218 (in Japanese)

26.

McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, Kanis JA (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3:138–147PubMedCrossRef

27.

Nathan H (1962) Osteophytes of the vertebral column. J Bone Joint Surg 44-A:243–269

28.

Sato Y, Tamaki J, Kitayama F, Kusaka Y, Kodera Y, Koutani A, Iki M (2005) Development of a food-frequency questionnaire to measure the dietary calcium intake of adult Japanese women. Tohoku J Exp Med 207:217–222PubMedCrossRef

29.

Garnero P, Hausher E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PG, Delmas PD (1996) Markers of bone resorption predict hip fracture in elderly women: the Eidos prospective study. J Bone Miner Res 11:1531–1538PubMedCrossRef

30.

Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the Ofely study. J Bone Miner Res 15:1526–1536PubMedCrossRef

31.

Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA (2000) Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 11:76–82PubMedCrossRef

32.

Luukinen H, Käkönen SM, Pettersson K, Koski K, Laippala P, Lövgren T, Kivelä SL, Väänänen HK (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:2473–2478PubMedCrossRef

33.

Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C (1996) Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study. Bone 19:9–12PubMedCrossRef

34.

Komukai S, Ohta H, Makita K, Yanamoto S, Takamatsu K, Okano H, Yajima M, Nozawa S (2003) One-year spinal bone change in pre- and perimenopausal Japanese women. Hormone Res 59:79–84PubMedCrossRef

35.

Picard D, Imback A, Couturier R, Lepage R, Ste-Marie LG (2000) Longitudinal study of bone density and its determinants in women in peri or early menopause. Calcif Tissue Int 67:356–360PubMedCrossRef

36.

Bastian LA, Smith CM, Nanda K (2003) Is this woman perimenopausal? JAMA 289:895–902PubMedCrossRef

37.

Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Rinaldi S, Kaaks R, Toniolo P (2003) Reliability of follicle-stimulating hormone measurements in serum. Reprod Biol Endocrinol 1:49PubMedCrossRef

Title: Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study
Authors: M. Iki
A. Morita
Y. Ikeda
Y. Sato
T. Akiba
T. Matsumoto
H. Nishino
S. Kagamimori
Y. Kagawa
H. Yoneshima ·
For the JPOS Study Group
Publication date: 01-07-2006
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 7/2006
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-005-0052-3

At a glance: The STEP trials

Springer Medicine

Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study

Abstract

Introduction

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2006

Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines

Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism

Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture

Dancing for bone health: a 3-year longitudinal study of bone mineral accrual across puberty in female non-elite dancers and controls

Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves’ disease